JP2023530245A5 - - Google Patents
Info
- Publication number
- JP2023530245A5 JP2023530245A5 JP2022575767A JP2022575767A JP2023530245A5 JP 2023530245 A5 JP2023530245 A5 JP 2023530245A5 JP 2022575767 A JP2022575767 A JP 2022575767A JP 2022575767 A JP2022575767 A JP 2022575767A JP 2023530245 A5 JP2023530245 A5 JP 2023530245A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063036539P | 2020-06-09 | 2020-06-09 | |
| US63/036,539 | 2020-06-09 | ||
| PCT/US2021/036443 WO2021252517A1 (en) | 2020-06-09 | 2021-06-08 | Engineered t cell receptors and methods of use |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023530245A JP2023530245A (ja) | 2023-07-14 |
| JP2023530245A5 true JP2023530245A5 (https=) | 2024-06-07 |
| JPWO2021252517A5 JPWO2021252517A5 (https=) | 2024-06-07 |
| JP7827645B2 JP7827645B2 (ja) | 2026-03-10 |
Family
ID=78845879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022575767A Active JP7827645B2 (ja) | 2020-06-09 | 2021-06-08 | 操作されたｔ細胞受容体および使用の方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230227526A1 (https=) |
| EP (1) | EP4161555A4 (https=) |
| JP (1) | JP7827645B2 (https=) |
| CN (1) | CN116096740A (https=) |
| CA (1) | CA3186594A1 (https=) |
| WO (1) | WO2021252517A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120718134B (zh) * | 2025-08-25 | 2025-12-26 | 北京立康生命科技有限公司 | 靶向col6a3肽的t细胞受体及其用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050010030A1 (en) * | 2003-07-02 | 2005-01-13 | Zang Jingwu Z. | T cell receptor CDR3 sequence and methods for detecting and treating rheumatoid arthritis |
| GB201004551D0 (en) * | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| IL290655B2 (en) * | 2014-05-29 | 2024-05-01 | Us Health | Anti-human papillomavirus 16 E7 T-cell chelates |
| EP3156067A1 (en) * | 2015-10-16 | 2017-04-19 | Max-Delbrück-Centrum Für Molekulare Medizin | High avidity hpv t-cell receptors |
| EP3452514A1 (en) * | 2016-05-06 | 2019-03-13 | Fred Hutchinson Cancer Research Center | T-cell immunotherapy specific for mart-1 |
| DE102016115246C5 (de) * | 2016-08-17 | 2018-12-20 | Immatics Biotechnologies Gmbh | Neue t-zellrezeptoren und deren verwendung in immuntherapie |
| TW201835100A (zh) * | 2017-02-06 | 2018-10-01 | 國立研究開發法人國立癌症研究中心 | 新穎ｔ細胞受體 |
| AU2018318303A1 (en) * | 2017-08-18 | 2020-04-09 | Gritstone Bio, Inc. | Antigen-binding proteins targeting shared antigens |
| EP4219543A1 (en) * | 2017-11-06 | 2023-08-02 | Immatics Biotechnologies GmbH | Novel engineered t cell receptors and immune therapy using the same |
| AU2019249209A1 (en) * | 2018-04-05 | 2020-10-15 | Juno Therapeutics, Inc. | T cell receptors and engineered cells expressing same |
-
2021
- 2021-06-08 CN CN202180057372.6A patent/CN116096740A/zh active Pending
- 2021-06-08 WO PCT/US2021/036443 patent/WO2021252517A1/en not_active Ceased
- 2021-06-08 CA CA3186594A patent/CA3186594A1/en active Pending
- 2021-06-08 US US18/001,185 patent/US20230227526A1/en active Pending
- 2021-06-08 EP EP21822596.9A patent/EP4161555A4/en not_active Withdrawn
- 2021-06-08 JP JP2022575767A patent/JP7827645B2/ja active Active